Thrombolytic refusal over telestroke
Citation Manager Formats
Make Comment
See Comments

Abstract
Introduction Tissue plasminogen activator (tPA) refusal is 4%–6% for acute ischemic stroke (AIS) in the emergency room. Telestroke (TS) has increased the use of tPA for AIS, but is accompanied by barriers in communication that can affect tPA consent. We characterized the incidence of tPA refusal in our TS network and its associated reasons.
Methods Patients with AIS who were offered tPA within 4.5 hours from symptom onset according to American Heart Association guidelines were identified within our Lone Star Stroke Consortium Telestroke Registry from September 2015 to December 2018. We compared baseline characteristics and clinical outcomes between patients who refused tPA and patients who accepted tPA.
Results Among the 1242 patients who qualified for tPA and were offered treatment, 8% refused tPA. Female and non-Hispanic black patients and patients with prior history of stroke were more likely to decline tPA. Patients who refused tPA presented with a lower NIHSS and was associated with a final diagnosis of stroke mimic (odds ratio [0.23]; 95% confidence interval [CI] 0.15–0.36). Good outcome (90 days modified Rankin Scale 0–2) was the same among patients who received tPA and those who refused (OR 0.80; 95% CI 0.42–1.54). The most common reasons for refusal were rapidly improving and mild/non-disabling symptoms and concern for potential side effects.
Conclusion tPA refusal over TS is comparable to previously reported rates; there was no difference in outcomes among patients who received tPA compared to those who refused. Sex and racial differences associated with an increase tPA refusal warrant further investigation in efforts to achieve equity/parity in tPA decisions.
Footnotes
↵* These authors have contributed equally to this manuscript.
- Received April 17, 2020.
- Accepted August 26, 2020.
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
The Nerve!: Rapid online correspondence
NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.cp.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.